MicroRNA-30c targets cytoskeleton genes involved in breast cancer cell invasion

Breast Cancer Research and Treatment

Volumn 137, Issue 2, 2013, Pages 373-382

  Bockhorn, Jessica ^a,b   Yee, Kathy ^a   Chang, Ya Fang ^a   Prat, Aleix ^c,e   Huo, Dezheng ^b   Nwachukwu, Chika ^b   Dalton, Rachel ^a   Huang, Simo ^a   Swanson, Kaitlin E ^a   Perou, Charles M ^c   Olopade, Olufunmilayo I ^b   Clarke, Michael F ^d   Greene, Geoffrey L ^a   Liu, Huiping ^a,d  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e VALL D HEBRON UNIVERSITY HOSPITAL   (Spain)

Author keywords

Breast tumor invasion; IL 11; miR 30c; TWF1; VIM

Indexed keywords

F ACTIN; INTERLEUKIN 11; MICRORNA; MICRORNA 30C; STAT3 PROTEIN; UNCLASSIFIED DRUG; VIMENTIN; ACTIN BINDING PROTEIN; IL11 PROTEIN, HUMAN; MIRN30 MICRORNA, HUMAN; PROTEIN TYROSINE KINASE; TWF1 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST METASTASIS; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION; GENE TARGETING; GENETIC ASSOCIATION; GENETIC CODE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR GENE; TUMOR INVASION; TWINFILIN 1 GENE; VIMENTIN GENE; ANIMAL; BREAST TUMOR; CYTOSKELETON; DRUG SCREENING; FEMALE; GENETICS; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; BASE SEQUENCE; BREAST NEOPLASMS; CELL LINE, TUMOR; CYTOSKELETON; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-11; MICE; MICROFILAMENT PROTEINS; MICRORNAS; MOLECULAR SEQUENCE DATA; PROTEIN-TYROSINE KINASES; VIMENTIN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MLCS; MLOWN;

EID: 84880590752     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-012-2346-4     Document Type: Article

References (25)

1. Sporn MB (1996) The war on cancer. Lancet 347(9012):1377-1381
2. Prat A, Perou CM (2011) Deconstructing the molecular portraits of breast cancer. Mol Oncol 5(1):5-23. doi: 10.1016/j.molonc.2010.11.003
3. Prat A, Parker JS, Karginova O, Fan C, Livasy C, Herschkowitz JI, He X, Perou CM (2010) Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res 12(5):R68. doi: 10.1186/bcr2635
4. Prat A, Perou CM (2009) Mammary development meets cancer genomics. Nat Med 15(8):842-844. doi: 10.1038/nm0809-842
5. Lim E, Vaillant F, Wu D, Forrest NC, Pal B, Hart AH, Asselin-Labat ML, Gyorki DE, Ward T, Partanen A, Feleppa F, Huschtscha LI, Thorne HJ, Fox SB, Yan M, French JD, Brown MA, Smyth GK, Visvader JE, Lindeman GJ (2009) Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med 15(8):907-913. doi: 10.1038/nm.2000
6. Bockhorn J, Dalton R, Nwachukwu C, Huang S, Prat A, Yee K, Chang Y-F, Huo D, Wen Y, Swanson KE, Qiu T, Lu J, Park SY, Dolan ME, Perou CM, Olopade OI, Clarke MF, Greene GL, Liu H (2012) MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11. Nature Commun (in press)
7. Yang J, Weinberg RA (2008) Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 14(6):818-829. doi: 10.1016/j.devcel.2008.05.009
8. Singh A, Settleman J (2010) EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 29(34):4741-4751. doi: 10.1016/j.devcel.2008.05.009
9. Meacham CE, Ho EE, Dubrovsky E, Gertler FB, Hemann MT (2009) In vivo RNAi screening identifies regulators of actin dynamics as key determinants of lymphoma progression. Nat Genet 41(10):1133-1137
10. Liu H, Patel MR, Prescher JA, Patsialou A, Qian D, Lin J, Wen S, Chang YF, Bachmann MH, Shimono Y, Dalerba P, Adorno M, Lobo N, Bueno J, Dirbas FM, Goswami S, Somlo G, Condeelis J, Contag CH, Gambhir SS, Clarke MF (2010) Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models. Proc Natl Acad Sci U S A 107(42):18115-18120
11. Team RDC (2011) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria
12. Buffa FM, Camps C, Winchester L, Snell CE, Gee HE, Sheldon H, Taylor M, Harris AL, Ragoussis J (2011) microRNA-associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancer. Cancer Res 71(17):5635-5645
13. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, Menard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I, Calin GA, Querzoli P, Negrini M, Croce CM (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65(16):7065-7070. doi: 10.1158/0008-5472.CAN-05-1783
14. Liu H (2012) MicroRNAs in breast cancer initiation and progression. Cell Mol Life Sci. doi: 10.1007/s00018-012-1128-9
15. Antonov AV, Dietmann S, Wong P, Lutter D, Mewes HW (2009) GeneSet2miRNA: finding the signature of cooperative miRNA activities in the gene lists. Nucleic Acids Res 37 (Web Server issue):W323-328. doi: 10.1093/nar/gkp313
16. Palmgren S, Vartiainen M, Lappalainen P (2002) Twinfilin, a molecular mailman for actin monomers. J Cell Sci 115(Pt 5):881-886
17. Ojala PJ, Paavilainen VO, Vartiainen MK, Tuma R, Weeds AG, Lappalainen P (2002) The two ADF-H domains of twinfilin play functionally distinct roles in interactions with actin monomers. Mol Biol Cell 13(11):3811-3821. doi: 10.1091/mbc.E02-03-0157
18. Poukkula M, Kremneva E, Serlachius M, Lappalainen P (2011) Actin-depolymerizing factor homology domain: a conserved fold performing diverse roles in cytoskeletal dynamics. Cytoskeleton (Hoboken) 68(9):471-490. doi: 10.1002/cm.20530
19. Ernst M, Najdovska M, Grail D, Lundgren-May T, Buchert M, Tye H, Matthews VB, Armes J, Bhathal PS, Hughes NR, Marcusson EG, Karras JG, Na S, Sedgwick JD, Hertzog PJ, Jenkins BJ (2008) STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice. J Clin Invest 118(5):1727-1738. doi: 10.1172/JCI34944
20. Schuringa JJ, Wierenga AT, Kruijer W, Vellenga E (2000) Constitutive Stat3, Tyr705, and Ser727 phosphorylation in acute myeloid leukemia cells caused by the autocrine secretion of interleukin-6. Blood 95(12):3765-3770
21. Brennecke J, Stark A, Russell RB, Cohen SM (2005) Principles of microRNA-target recognition. PLoS Biol 3(3):e85. doi: 10.1371/journal.pbio. 0030085
22. Li N, Kaur S, Greshock J, Lassus H, Zhong X, Wang Y, Leminen A, Shao Z, Hu X, Liang S, Katsaros D, Huang Q, Butzow R, Weber BL, Coukos G, Zhang L (2012) A combined array-based comparative genomic hybridization and functional library screening approach identifies mir-30d as an oncomir in cancer. Cancer Res 72(1):154-164. doi: 10.1158/0008-5472.CAN-11-2484
23. Gaziel-Sovran A, Segura MF, Di Micco R, Collins MK, Hanniford D, de Vega-Saenz Miera E, Rakus JF, Dankert JF, Shang S, Kerbel RS, Bhardwaj N, Shao Y, Darvishian F, Zavadil J, Erlebacher A, Mahal LK, Osman I, Hernando E (2011) miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis. Cancer Cell 20(1):104-118. doi: 10.1016/j.ccr.2011.05.027
24. Elson-Schwab I, Lorentzen A, Marshall CJ (2010) MicroRNA-200 family members differentially regulate morphological plasticity and mode of melanoma cell invasion. PloS one 5 (10). doi: 10.1371/journal.pone.0013176
25. Cheng CW, Wang HW, Chang CW, Chu HW, Chen CY, Yu JC, Chao JI, Liu HF, Ding SL, Shen CY (2012) MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer. Breast Cancer Res Treat 134(3):1081-1093. doi: 10.1007/s10549-012-2034-4